We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Rhythm Pharmaceuticals
RYTM
$7.96B
| $1.38M | ﹤0.01% |
47,491
+7,201
| +18% | +$185K |
|
|
ILPT
2502
Industrial Logistics Properties Trust
ILPT
$586M
| $1.38M | ﹤0.01% |
422,372
-124,509
| -23% | -$518K |
|
2503
Beazer Homes USA
BZH
$907M
| $1.38M | ﹤0.01% |
107,942
-19,049
| -15% | -$231K |
|
|
CSTR
2504
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.37M | ﹤0.01% |
77,789
-6,231
| -7% | -$111K |
|
|
TVRD
2505
Tvardi Therapeutics
TVRD
$23.4M
| $1.37M | ﹤0.01% |
3,545
-567
| -14% | -$215K |
|
2506
KRONOS Worldwide
KRO
$989M
| $1.37M | ﹤0.01% |
145,642
+49,070
| +51% | +$464K |
|
2507
Allogene Therapeutics
ALLO
$694M
| $1.37M | ﹤0.01% |
217,349
-129,820
| -37% | -$1.2M |
|
2508
Transcat
TRNS
$871M
| $1.36M | ﹤0.01% |
19,261
-1,087
| -5% | -$82.8K |
|
2509
Lindblad Expeditions
LIND
$2.22B
| $1.36M | ﹤0.01% |
177,137
+14,679
| +9% | +$124K |
|
|
GOEV
2510
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $1.36M | ﹤0.01% |
2,409
+1,178
| +96% | +$722K |
|
2511
Capital City Bank Group
CCBG
$890M
| $1.36M | ﹤0.01% |
41,863
-5,465
| -12% | -$186K |
|
2512
F&G Annuities & Life
FG
$3.62B
| $1.36M | ﹤0.01% |
+67,981
| New | +$1.39M |
|
2513
Unisys
UIS
$217M
| $1.36M | ﹤0.01% |
265,997
-11,967
| -4% | -$75.1K |
|
|
ORGN
2514
DELISTED
Origin Materials
ORGN
| $1.36M | ﹤0.01% |
9,821
-1,384
| -12% | -$220K |
|
2515
Bionano Genomics
BNGO
$13.3M
| $1.36M | ﹤0.01% |
1,548
-197
| -11% | -$248K |
|
|
BBUC
2516
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.04B
| $1.35M | ﹤0.01% |
72,094
-4,061
| -5% | -$88.4K |
|
2517
Peoples Financial Services
PFIS
$707M
| $1.35M | ﹤0.01% |
26,143
-4,048
| -13% | -$216K |
|
2518
Destination XL Group
DXLG
$35.4M
| $1.35M | ﹤0.01% |
200,370
-11,786
| -6% | -$75.5K |
|
|
NPKI
2519
NPK International
NPKI
$1.14B
| $1.35M | ﹤0.01% |
324,182
-45,986
| -12% | -$168K |
|
|
ME
2520
DELISTED
23andMe Holding Co
ME
| $1.35M | ﹤0.01% |
31,178
-13,360
| -30% | -$778K |
|
|
CMRC
2521
Commerce.com Inc Series 1
CMRC
$184M
| $1.34M | ﹤0.01% |
153,935
-8,144
| -5% | -$88.2K |
|
|
GBIO
2522
DELISTED
Generation Bio
GBIO
| $1.34M | ﹤0.01% |
34,206
-1,659
| -5% | -$87.1K |
|
2523
Noodles & Co
NDLS
$107M
| $1.34M | ﹤0.01% |
30,532
+388
| +1% | +$17K |
|
|
DX
2524
Dynex Capital
DX
$3.21B
| $1.34M | ﹤0.01% |
105,358
-14,423
| -12% | -$179K |
|
2525
SmartFinancial
SMBK
$888M
| $1.34M | ﹤0.01% |
48,632
-7,046
| -13% | -$198K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.